Published in Managed Care Weekly Digest, July 4th, 2005
Contrary to what Patrick Sullivan, PhD, of the University of Colorado School of Pharmacy, and colleagues expected, patients did not turn to other prescription drugs for allergies and asthma or to antibiotics in greater numbers after loratadine lost its prescription-only status. Their findings were published in the American Journal of Managed Care.
"Instead, there were fewer prescriptions and lower costs for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.